Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24366930 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)
Condition: Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Drug: Thioguanine;   Drug: Daunorubicin;   Drug: Cyclophosphamide;   Drug: G-CSF;   Procedure: Autologous stem cell transplantation;   Procedure: Allogeneic stem cell transplantation

Indicates status has not been verified in more than two years